Literature DB >> 16574228

GCSF receptor regulates antigen uptake and expression of cytokines and costimulatory molecules in dendritic cells.

Degui Geng1, Sunil K Joshi, Robert Podolsky, Jin-Xiong She.   

Abstract

RNA interference (RNAi), a process that specifically silences target gene expression, is a powerful technique to modulate cellular functions. In this study, we identified two small interference RNA (siRNA) sequences that can specifically and efficiently silence the expression of the granulocyte colony-stimulating factor receptor (GCSF-R) gene and achieved stable knockdown of GCSF-R using pFIV lentivirus containing the GCSF-R siRNA. GCSF-R knockdown significantly reduces the expression of IL-lalpha, IL-lbeta, IL-6, IL-10, H-2Kb, I-Ab, CD80 and CD86, and increases PDL1 and PDL2 expression, while IL-12p35, TGFbeta, TNFalpha and CD40 expression is unaltered. Furthermore, GCSF-R knockdown significantly changes the endocytosis and micro-pinocytosis abilities as well as surface expression of antigens of DC2.4 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574228     DOI: 10.1016/j.molimm.2006.02.009

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

1.  Lung transplant outcomes are influenced by severity of neutropenia and granulocyte colony-stimulating factor treatment.

Authors:  Laneshia Karee Tague; Davide Scozzi; Michael Wallendorf; Brian F Gage; Alexander S Krupnick; Daniel Kreisel; Derek Byers; Ramsey R Hachem; Andrew E Gelman
Journal:  Am J Transplant       Date:  2019-09-26       Impact factor: 8.086

2.  Dendritic cell profile induced by Schistosoma mansoni antigen in cutaneous leishmaniasis patients.

Authors:  Diego Mota Lopes; Jamille Souza Fernandes; Thiago Marconi de Souza Cardoso; Aline Michele Barbosa Bafica; Sérgio Costa Oliveira; Edgar M Carvalho; Maria Ilma Araujo; Luciana Santos Cardoso
Journal:  Biomed Res Int       Date:  2014-09-17       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.